May 28, 2025, 13:05
Antiphospholipid Syndrome (APS) Management: A 2024 Update and Review
Rheuma Doc – shared a post on X:
“A Nice Summary of Recommendations for the treatment of Antiphospholipid Syndrome (APS) [F.Bashal et al]․
‘Clinical Advances in APS: Evidence-Based Guidance for Rheumatologists and Hematologists.'”
Title: Thrombosis in Rheumatological Diseases
Author: Fozya Bashal
The article is quite interesting and has been featured on Hemostasis Today.
-
Dec 11, 2025, 12:34Riitta Lassila on LMWH Benefits in COVID19
-
Dec 11, 2025, 12:30A Neutrophil-Mesangial Cell Axis Promotes Glomerular Injury in Lupus Nephritis
-
Dec 11, 2025, 12:27Roula Farah: Discussing Rare Bleeding Disorders in Abu Dhabi
-
Dec 11, 2025, 12:21Amirali Ebrahimpour: Escherichia coli–Related DIC Case Report
-
Dec 11, 2025, 12:08Laura Girardi Compares US, CT and MRI in Portal Vein Thrombosis
-
Dec 11, 2025, 11:55Dino Mehic on BDUC: What Do We Know?
-
Dec 11, 2025, 11:39Post‑ASH25 Reflection from Hollie Knight: The Magic Isn’t Just in the Data, It’s in How We Move It
-
Dec 11, 2025, 06:23Robert Negrin is the President of ASH for 2026
-
Dec 10, 2025, 23:50Abdul Mannan: Two Battles, One Patient – Why Women on Anticoagulants Need Better Coordinated Care